Archive: news

• Aducanumab (AduhelmTM) – the first disease-modifying treatment for Alzheimer’s disease approved by the US Food and Drug Administration, 7 June 2021

  Availability of Aduhelm remains unclear Coverage by Medicare and other third-party payers unknown More information to follow R. Scott Turner, PhD, MD, and the Memory Disorders Program On

  Category: News Tags: Aducanumab, Alzheimer's disease, alzheimers, disease modifying, FDA, news, treatment

• Study Researches Whether Nicotine Patch Can Help People With Memory Loss

  The clinical trial is the largest and longest of its kind, enrolling up to 300 people in 23 states to test the theory.

  Category: News Tags: aging, Alzheimer's disease, attention, channel 4, clinical trials, dementia, Georgetown University, memory, memory disorders program, mind, news, nicotine, R. Scott Turner